MeSH tree: D03.132.436.613
An international collaboration led by Cornell researchers used a combination of psilocybin and the rabies virus to map how—and where—the psychedelic compound rewires the connections in the brain.
Dec 6, 2025
0
119
People who have received emergency or hospital care in Canada due to hallucinogen use have a six-fold increased risk of receiving care for mania in the next three years, according to a study published in PLOS Medicine by ...
Dec 2, 2025
0
21
As interest in psychedelics surges across the United States, a new study led by researchers at the University of Michigan and the University at Buffalo offers critical harm-reduction guidance for individuals considering their ...
Dec 2, 2025
0
23
Researchers from the University of Liège and international collaborators developed a "virtual clinical trial" exploring a unique pharmacological treatment in patients who do not fully regain consciousness after a coma. The ...
Nov 24, 2025
0
50
Investor appetite in corporate psychedelia is returning, but the sector faces fundamental barriers to profitability, according to new research.
Nov 20, 2025
0
26
A study published in JAMA Network Open analyzed national hospital admission data from 2016 to 2023 to assess whether decriminalizing psychedelics—such as psilocybin ("magic mushrooms")—has led to more people needing emergency ...
Nov 19, 2025
0
83
The term intimate partner violence (IPV) refers to physical, sexual or psychological abuse perpetrated by an individual on their romantic partner or spouse. Victims of IPV who are violently attacked and physically abused ...
In clinical trials around the world, a surprising treatment is showing promise for people with terminal illnesses: psychedelic therapy.
Nov 17, 2025
0
53
Everything in moderation. Including moderation. That's the idea behind the Colorado sober movement, an unofficial yet growing trend away from alcohol, and toward plant-based and psychedelic drugs.
Oct 28, 2025
0
20
Psilocybin could be the future of mental health care, with promising findings emerging from Australia's first research trial using psychedelics to treat depression, led by Swinburne University of Technology.
Oct 14, 2025
0
22
